Pharmacological blockade of the JAK/STAT3 pathway has been shown to reduce muscle atrophy in C26‐driven cachexia, suggesting a significant role for this pathway in IL‐6/gp130‐mediated cachexia.332, 333, 862. The gene discussed is STAT3; the disease is Cachexia.